Saifullah Khan

8PUBLICATIONS
25CO-AUTHORS
Pharmaceutical delivery technologiesGene and molecular therapyCardiology (incl. cardiovascular diseases)Epidemiological modellingMortality
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 28, 2026
Comparison of the Safety and Effectiveness of Apixaban Versus Rivaroxaban in Acute Venous Thromboembolism: A Propensity-Matched Real-World TriNetX Study with Obesity and Cancer Subgroup Analyses.

|Jun 26, 2026
Clinical Outcomes of GLP-1 Receptor Agonist and SGLT2 Inhibitor Combination Therapy in Heart Failure: A Real-World Propensity-Matched TriNetX Analysis.

|Jun 25, 2026
Cardiovascular Outcomes with Colchicine in Coronary Artery Disease and HFpEF: A Propensity-Matched TriNetX Analysis.

|Jun 19, 2026
Temporal trends and forecasted mortality involving lung cancer with co-listed hypertension in U.S. adults, 2000-2035.

|May 29, 2026
Unveiling temporal trends and disparities in mortality with co-listed coronary artery disease and cancer, 1999-2024: insights from the CDC WONDER multiple cause of death database.

|May 27, 2026
Comparative Effectiveness of Finerenone Versus SGLT2 Inhibitors in Patients with HFpEF and CKD: A Real-World Propensity-Matched TriNetX Analysis.

Pageof 2

Frequent Collaborators

5 joint publications

Muhammad Hussain

5 joint publications

Muhammad Hassan

4 joint publications

Mohammad Omar Butt

4 joint publications

Haris Bin Tahir